|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Investments | |||||||||||||||||
| Non-Controlled, Affiliated Investments | |||||||||||||||||
| Controlled Affiliate | |||||||||||||||||
| Non-Controlled, Non-Affiliated Investments | |||||||||||||||||
| Controlled Investments | |||||||||||||||||
| Total controlled Affiliate | |||||||||||||||||
| Total investments | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Interest, dividends and fees receivable | |||||||||||||||||
| Deferred debt issuance costs | |||||||||||||||||
| Receivable for investments sold | |||||||||||||||||
| Due from broker | |||||||||||||||||
| Prepaid expenses and other assets | |||||||||||||||||
| Total assets | |||||||||||||||||
| Liabilities | |||||||||||||||||
| Debt (net of deferred issuance costs of $3,431,843 and $5,299,866, respectively) | |||||||||||||||||
| Interest and debt related payables | |||||||||||||||||
| Management fees payable | |||||||||||||||||
| Reimbursements due to the Advisor | |||||||||||||||||
| Distributions payable | |||||||||||||||||
| Accrued expenses and other liabilities | |||||||||||||||||
| Interest Rate Swap, at fair value | |||||||||||||||||
| Payable for investments purchased | |||||||||||||||||
| Incentive fees payable | |||||||||||||||||
| Total liabilities | |||||||||||||||||
| Net Assets | |||||||||||||||||
| Composition of net assets applicable to common shareholders | |||||||||||||||||
| Common stock, $0.001 par value; 200,000,000 shares authorized, 83,902,775 and 84,564,578 shares issued and outstanding as of September 30,2026 and December 31,2025, respectively | |||||||||||||||||
| Paid-in capital in excess of par | |||||||||||||||||
| Distributable earnings (loss) | |||||||||||||||||
| Total net assets | |||||||||||||||||
| Total liabilities and net assets | |||||||||||||||||
| Net assets per share |
Loading...